Biotech Is Great at Science. It Is Terrible at Explaining It.

Biotech is great at science. It is terrible at explaining it.

Our industry is full of brilliant minds solving impossible problems.

But if you ask the average person about biotech, they don’t think miracles. They think price gouging.

Why?

Because the industry has let others write its narrative.

If we want better policy and stronger public trust, we need to hammer home three simple truths:

1. The Iceberg Effect People see the price tag at the counter. They don’t see the decade of risk and failure behind a single success.

2. The Lifecycle of Value Innovation is expensive today, but genericization makes it incredibly affordable for society tomorrow. Today’s blockbusters become tomorrow’s cheap generics

3. The Insurance Gap Most access horror stories come from insurance design and high deductibles, not from the innovation itself.

If the industry told this story in plain English, the conversation around access would shift overnight.

Biotech doesn’t just need more innovation. It needs more translators. If the industry gets this right, everything else gets easier.